Automated Method to Determine Infectious Dose (TCID50)
Poster Sep 14, 2014
Andrea Murphy, PhD and Catherine Swingler, PhD
Qualitative assessment of pathogenic infections, as well as the protective effects of candidate therapeutics, often relies on the observation of specific pathological changes within the host cell. These phenotypic changes, such as cell rounding, swelling/shrinking, granularity, etc., are known as a Cytopathic Effect (CPE) and can be visualized via light microscopy. As the magnitude and localization of the CPE may vary considerably, careful examination of replicate samples at various titers is required for reliable, qualitative results. This subjective approach which is specific to the infectious agent as well as the host cell is tedious, time consuming and low throughput, requiring manual well-bywell examination by highly skilled personnel.
Nexcelom’s Celigo imaging cytometer has been applied to provide automated, rapid assessment of viral infectivity in a range of plate formats. Using f-theta optics, Celigo provides high quality, whole well images using brightfield and/or fluorescent illumination. Automated segmentation and analysis provides quantitative output of CPE based on characteristic changes to the host cell monolayer.
Celigo provides several key benefits;
• Objective segmentation and quantitative output of magnitude of infection
• Automated sample analysis reduces time, labor and variability
• High throughput and scaleable – less than 5 min for 96 or 384 well plate
• Capture high resolution, whole well images for documentation or manual assessment of CPE
• Supports related fluorescent based functional assays relevant to infection (e.g. expression analysis, apoptosis)
Despite the developments in conventional PCR, the complexity of multiplex Real Time PCR is still limited due to the lack of sufficient detection channels. To achieve high-end multiplexing capacity on standard Real Time PCR machines, Anapa Biotech has developed the MeltPlex® technology (see box on right).READ MORE
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE